Table showing various modified oligonucleotides synthesized using UnyLinker loaded solid supports.

Size: px
Start display at page:

Download "Table showing various modified oligonucleotides synthesized using UnyLinker loaded solid supports."

Transcription

1 Table showing various modified oligonucleotides synthesized using UnyLinker loaded solid supports. Oligo Synthesized Sequence 5 3 Oligo 1 2 -O-Methoxyethyl modified phosphorothioate 2- nucleotide gapmer ISIS Oligo 2 [CTG]-AGTCTGTTT-[TCCATTCT] Oligo 3 Oligo 4 Oligo 5 Oligo 6 Oligo 7 Oligo 8 [GCTCC]-TTCCACTGAT-[CCTGC] [GCCTC]-AGTCTGCTTC[GCACC] [TGGAA]-AGGCTTATAC-[CCCTC] [TCCCGC]-CTGTGACA-[TGCATT] d[gcccaagctggcatccgtca] [CAGC]-AGCAGAGTCTTCA-[TCAT] Oligo Synthesized Sequence 5 3 Oligo #9 5 -PO-d[AATGCATGTCACAGGCGGGA] Oligo #1 Oligo #11 Oligo #12 Oligo #13 Oligo #14 Oligo #15 Oligo #16 Oligo #17 m C ms T m ms C mo A mo G m mo C mo A m mo C mo A mo T m mo C mo T mo A m mo C mo A mo A mo G ms A ms A ms A m C ms T m ms C ms A ms G m ms C ms A m ms C ms A ms T m ms C ms T ms A m ms C ms A ms A ms G ms A ms A ms A A ro A eo G ro C eo A ro A eo C ro G eo A ro G eo A ro A eo G ro C eo G ro A eo U ro A eo A r 5 -A m es C es A m es C es A es A es A es T es T m es C es G es G es T es T m es C es T es A m es C es A es G es G es G e PO 3 -U ro U ro A ro U ro C ro G mo C mo U ro U ro C mo U mo C ro G ro U ro U ro G ro C mo U mo U m 5 - m C es G m es C es G es T es A m es C m es C es A es A es A es A es G es T es A es A es T es A es A es T es G e m C es U m fs C es A fs G es C fs A es C fs A es U m fs C es U fs A es C fs A es A fs G es A es A e 5 -T m es C es A m es C es A es A es G es T es T es A es G es G es G es T m es C es T m es C es A es G es G es G es A e S33

2 Oligo #18 Oligo #19 Oligo #2 Oligo #21 Oligo #22 Oligo #23 Oligo #24 Oligo #25 Oligo #26 Oligo #27 Oligo #28 Oligo #29 Oligo #3 Oligo #31 Oligo #32 Oligo #33 Oligo #34 Oligo #35 Oligo #36 Oligo #37 5 -G m es C es T m es C es A es T es T es T es A es G es T m es C es T es G m es C m es C es T es G es A es T e m C ls T ls G ds C ds T ds A ds G ds C ds C ds T ds C ds T ds G ds G ds A ds T ds T ds T ds G ls A l m C lo T lo G ds C ds T ds A ds G ds C ds C ds T ds C ds T ds G ds G ds A ds T ds T ds T do G lo A l 5 -A m es C es A es T es A m es C es T m es C m es C es T es T es T es m C es T m es C es A es G es A es G es T m es C m es C es A e T ls T ls G ls T ds T ds C ds T ds G ds A ds A ds T ds G ds T ds m C ls m C ls A l 5 -A es A m es C m es C es T es A es T m es C m es C es T es G es A es A es T es T es A m es C es T es T es G es A es A e 5 -A m ms C ms A ms A ms A m ms C ms A m ms C m ms C ms A ms T ms T ms G ms T m ms C ms A m ms C ms A m ms C ms T m ms C m ms C ms A m 5 -PO-d[GAGGGGTATAAGCCTTTCCA] G m ls C ls T m ls C ls A ds T ds A m ds C ds T m ds C ds G ds T ds A ds G ds G m ls C m ls C ls A l 5 -G m es C es A m ds C ds T ds T ds T ds G ds T ds G ds G ds T ds G m ds C m ds C ds A ds A ds G ds G m es C e 5 - m C m es C ds A ds G m ds C ds A ds T m ds C ds T ds G m ds C ds T ds G m es C es T es T m es C e 5 - m C es T m ds C es A ds G m es C ds A m es C ds A es T m ds C es T ds A m es C ds A es A ds G es A ds A es A e 5 -Biotin-G es A es A es G es T es A ds G m ds C m ds C ds A ds m C m ds C ds A ds A m ds C ds T es G es T es G m es C e 5 - m C es T fs C fs A fs G fs C fs A fs C fs A fs T fs C fs T fs A fs C fs A fs A fs G fs A fs A es A e 5 -PO 3 -A ro U ro A ro G ro A ro C mo U mo U ro C ro A mo U mo C ro C ro U ro U ro G ro U mo U mo G m 5 -U ro A ro C ro G ro C ro A mo A mo A ro C ro C mo U mo U ro G ro A ro U ro G ro U mo C mo C m 5 - PO 3 -A ro A ro A ro U ro G ro U mo U mo C ro C ro A mo G mo C ro C ro C ro A ro G ro G mo G mo C m 5 -G ro G eo A ro C eo A ro U eo C ro A eo A ro G eo G ro U eo U ro U eo G ro C eo G ro U eo A r 5 -U ro C ro A ro C ro U ro C ro G ro G ro C ro U ro G ro G ro A ro U ro G ro G ro A ro G ro U rs T es T 5 -[CTCTA]-GTTCCTCTCA-[ATGTC] (for plate synthesis comparison) S34

3 Table: Oligonucleotides synthesized on GE Amersham Akta 1/1 and other automated DNA/RNA synthesizers. m C = 5-methyl C; d = 2 -deoxy; e = 2 -O-methoxyethyl; m = 2 - O-methyl; r = 2 -OH; l = LNA; f = 2 -alpha-fluoro; o = PO; s = PS; PO 3 = phosphate monoester. S35

4 IP-HPLC-MS of 2 -O-methoxyethyl modified phosphorothioate Oligo 1 ma 4 A mi B m/ Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S36

5 IP-HPLC-MS of 2 -O-methoxyethyl modified phosphorothioate Oligo 2 5 -[CTG]-AGTCTGTTT-[TCCATTCT]-3 mau A mi B m/ Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S37

6 IP-HPLC-MS of 2 -O-methoxyethyl modified phosphorothioate Oligo 3 5 -[GCTCC]-TTCCACTGAT-[CCTGC]-3 ma 35 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S38

7 IP-HPLC-MS of 2 -O-methoxyethyl modified phosphorothioate Oligo 4 5 -[GCCTC]-AGTCTGCTTC-[GCACC]-3 ma A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S39

8 IP-HPLC-MS of 2 -O-methoxyethyl modified phosphorothioate Oligo 5 5 -[TGGAA]-AGGCTTATAC-[CCCTC]-3 ma 35 A min 18.6 B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S4

9 IP-HPLC-MS of DMT-on crude 2 -O-methoxyethyl modified phosphorothioate Oligo 6 5 -[TCCCGC]-CTGTGACA-[TGCATT]-3 mau 25 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S41

10 IP-HPLC-MS of DMT-on reversed phase purified 2 -O-methoxyethyl modified phosphorothioate Oligo 6 5 -[TCCCGC]-CTGTGACA-[TGCATT]-3 mau 4 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S42

11 IP-HPLC-MS of crude DMT-on oligodeoxy phosphorothioate Oligo 7- SYN #1 5 -GCCCAAGCTGGCATCCGTCA-3 mau A min B m/z Upper panel (A): HPLC-UV trace of the crude synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S43

12 IP-HPLC-MS of oligodeoxy phosphorothioate Oligo 7- SYN #1 5 -GCCCAAGCTGGCATCCGTCA-3 ma 4 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S44

13 IP-HPLC-MS of crude DMT-on oligodeoxy phosphorothioate Oligo 7- SYN #2 5 -GCCCAAGCTGGCATCCGTCA-3 mau A min B m/z Upper panel (A): HPLC-UV trace of the crude synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S45

14 IP-HPLC-MS of crude DMT-on oligodeoxy phosphorothioate Oligo 7- SYN #3 5 -GCCCAAGCTGGCATCCGTCA-3 mau A min B m/z S46

15 Capillary gel electropherogram (CGE) analysis of oligodeoxy phosphorothioate 7 using da-loaded solid support. S47

16 IP-HPLC-MS analysis of 2 -O-methoxyethyl modified phosphorothioate Oligo 8 5 -[CAGC]-AGCAGAGTCTTCA-[TCAT]-3 mau 4 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S48

17 IP-HPLC-MS of DMT-on crude 2 -O-methoxyethyl modified phosphorothioate Oligo 9 5 -PO-d[AATGCATGTCACAGGCGGGA]-3 mau 6 A mi B m/ Upper panel (A): HPLC-UV trace of the synthesized oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S49

18 IP-HPLC-MS analysis of 2 -O-methyl modified phosphate/phosphorothioate mixed backbone Oligo 1 using UnyLinker loaded CPG solid support 5 - m C ms T m ms C mo A mo G m mo C mo A m mo C mo A mo T m mo C mo T mo A m mo C mo A mo A mo G ms A ms A ms A-3 mau A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S5

19 IP-HPLC-MS analysis of 2 -O-methyl modified phosphorothioate Oligo 11 using UnyLinker loaded CPG solid support 5 - m C ms T m ms C ms A ms G m ms C ms A m ms C ms A ms T m ms C ms T ms A m ms C ms A ms A ms G ms A ms A ms A-3 mau 7 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S51

20 IP-HPLC-MS analysis of 2 -O-methoxyethyl/RNA modified sequence with phosphate backbone Oligo 12 using UnyLinker loaded CPG solid support 5 -A ro A eo G ro C eo A ro A eo C ro G eo A ro G eo A ro A eo G ro C eo G ro A eo U ro A eo A r -3 mau 12 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S52

21 IP-HPLC-MS analysis of 5 -phosphate-2 -O-methyl/RNA modified sequence with phosphate backbone Oligo 13 using UnyLinker loaded CPG solid support 5 -A m es C es A m es C es A es A es A es T es T m es C es G es G es T es T m es C es T es A m es C es A es G es G es G e -3 mau 7 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S53

22 IP-HPLC-MS analysis of 5 -phosphate-2 -O-methyl/RNA modified phosphate Oligo 14 using UnyLinker loaded CPG solid support 5 -PO 3 -U ro U ro A ro U ro C ro G mo C mo U ro U ro C mo U mo C ro G ro U ro U ro G ro C mo U mo U m -3 mau 7 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S54

23 IP-HPLC-MS analysis of 2 -O-methoxyethyl/RNA modified sequence with phosphate backbone Oligo 15 using UnyLinker loaded CPG solid support 5 - m C es G es m C es G es T es A es m C es m C es A es A es A es A es G es T es A es A es T es A es A es T es G e -3 mau 8 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S55

24 IP-HPLC-MS analysis of 2 -O-methoxyethyl/2 -alpha-fluoro modified phosphorothioate Oligo 16 using UnyLinker loaded CPG solid support 5 - m C es U fs m C es A fs G es C fs A es C fs A es U fs m C es U fs A es C fs A es A fs G es A es A e -3 mau 1 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S56

25 IP-HPLC-MS analysis of 2 -deoxy/lna modified phosphorothioate Oligo 17 using UnyLinker loaded CPG solid support 5 -T es m C es A es m C es A es A es G es T es T es A es G es G es G es T es m C es T es m C es A es G es G es G es A e -3 mau 8 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S57

26 IP-HPLC-MS analysis of modified phosphorothioate Oligo 18 using UnyLinker loaded CPG solid support 5 -G es m C es T es m C es A es T es T es T es A es G es T es m C es T es G es m C es m C es T es G es A es T e -3 mau 6 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S58

27 IP-HPLC-MS analysis of modified phosphorothioate Oligo 19 using UnyLinker loaded CPG solid support 5 - m C ls T ls G ds C ds T ds A ds G ds C ds C ds T ds C ds T ds G ds G ds A ds T ds T ds T ds G ls A l -3 mau 8 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S59

28 IP-HPLC-MS analysis of 2 -deoxy/lna modified phosphate/phosphorothioate mixed backbone Oligo 2 using UnyLinker loaded CPG solid support 5 - m C lo T lo G ds C ds T ds A ds G ds C ds C ds T ds C ds T ds G ds G ds A ds T ds T ds T do G lo A l -3 mau 8 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S6

29 IP-HPLC-MS analysis of modified phosphorothioate Oligo 21 using UnyLinker loaded CPG solid support 5 -A es m C es A es T es A es m C es T es m C es m C es T es T es T es m C es T es m C es A es G es A es G es T es m C es m C es A e -3 mau 5 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S61

30 IP-HPLC-MS analysis of 2 -deoxy/lna modified phosphorothioate Oligo 22 using UnyLinker loaded CPG solid support 5 -T ls T ls G ls T ds T ds C ds T ds G ds A ds A ds T ds G ds T ds m C ls m C ls A l -3 mau 14 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S62

31 IP-HPLC-MS analysis of modified phosphorothioate Oligo 23 using UnyLinker loaded CPG solid support 5 -A es A es m C es m C es T es A es T es m C es m C es T es G es A es A es T es T es A es m C es T es T es G es A es A e -3 mau 7 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S63

32 IP-HPLC-MS analysis of 2 -deoxy/lna modified phosphorothioate Oligo 24 using UnyLinker loaded CPG solid support 5 -A ms m C ms A ms A ms A ms m C ms A ms m C ms m C ms A ms T ms T ms G ms T ms m C ms A ms m C ms A ms m C ms T ms m C ms m C ms A m -3 mau A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S64

33 IP-HPLC-MS analysis of modified Oligo 25 using UnyLinker loaded CPG solid support 5 -PO-d[GAGGGGTATAAGCCTTTCCA]-3 mau 1 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S65

34 IP-HPLC-MS analysis of 2 -deoxy/lna modified phosphorothioate Oligo 26 using UnyLinker loaded CPG solid support 5 -G ls m C ls T ls m C ls A ds T ds A ds m C ds T ds m C ds G ds T ds A ds G ds G ls m C ls m C ls A l -3 mau 5 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S66

35 IP-HPLC-MS analysis of modified Oligo 27 using UnyLinker loaded solid support 5 -G es m C es A ds m C ds T ds T ds T ds G ds T ds G ds G ds T ds G ds m C ds m C ds A ds A ds G ds G es m C e -3 mau 4 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S67

36 IP-HPLC-MS analysis of modified phosphorothioate Oligo 28 made using UnyLinker solid support 5 - m C es m C ds A ds G ds m C ds A ds T ds m C ds T ds G ds m C ds T ds G es m C es T es T es m C e -3 mau 6 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S68

37 IP-HPLC-MS analysis of modified phosphorothioate Oligo 29 made using UnyLinker solid support 5 - m C es T ds m C es A ds G es m C ds A es m C ds A es T ds m C es T ds A es m C ds A es A ds G es A ds A es A e -3 mau 7 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S69

38 IP-HPLC-MS analysis of modified phosphorothioate Oligo 3 made using UnyLinker solid support 5 -Biotin-G es A es A es G es T es A ds G ds m C ds m C ds A ds m C ds m C ds A ds A ds m C ds T es G es T es G es m C e -3 mau A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S7

39 IP-HPLC-MS analysis of modified phosphorothioate Oligo 31 made using UnyLinker solid support 5 -C es U fs C fs A fs G fs C fs A fs C fs A fs U fs C fs U fs A fs C fs A fs A fs G fs A fs A es A e -3 mau A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S71

40 IP-HPLC-MS analysis of modified Oligo 32 made using UnyLinker solid support 5 -PO 3 -A ro U ro A ro G ro A ro C mo U mo U ro C ro A mo U mo C ro C ro U ro U ro G ro U mo U mo G m -3 mau 8 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S72

41 IP-HPLC-MS analysis of modified Oligo 33 made using UnyLinker solid support 5 -U ro A ro C ro G ro C ro A mo A mo A ro C ro C mo U mo U ro G ro A ro U ro G ro U mo C mo C m -3 mau 7 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S73

42 IP-HPLC-MS analysis of modified Oligo 34 made using UnyLinker solid support 5 - PO 3 -A ro A ro A ro U ro G ro U mo U mo C ro C ro A mo G mo C ro C ro C ro A ro G ro G mo G mo C m -3 mau A min B m/z Upper panel (A): HPLC-UV trace of the synthesized oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S74

43 IP-HPLC-MS analysis of modified Oligo 35 made using UnyLinker solid support 5 -G ro G eo A ro C eo A ro U eo C ro A eo A ro G eo G ro U eo U ro U eo G ro C eo G ro U eo A r -3 mau 12 A min B m/z Upper panel (A): HPLC-UV trace of the synthesized oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S75

44 IP-HPLC-MS analysis of modified phosphate/phosphorothioate Oligo 36 made using UnyLinker solid support 5 -U ro C ro A ro C ro U ro C ro G ro G ro C ro U ro G ro G ro A ro U ro G ro G ro A ro G ro U rs T es T-3 mau 6 A mi 1 B m/ Upper panel (A): HPLC-UV trace of the synthesized phosphate/phosphorothioate oligonucleotide. Lower panel (B): The average mass spectrum under the parent peak. S76

45 IP-HPLC-MS of 2 -O-methoxyethyl modified phosphorothioate Oligo synthesized using MOE A nucleoside solid support 5 -[CCGTC]-GCCCTTCAGC-[ACGCA]-3 mau 3 A min mau B min Upper panel (A): The average mass spectrum under the parent peak. Lower panel (B): HPLC-UV trace of the synthesized phosphorothioate oligonucleotide. S77

46 Table 1. Analysis of 2 -O-methoxyethyl modified phosphorothioate Oligo 1 made using UnyLinker loaded solid support on OligoProcess Sequence: Oligo 1 Results (%) Full length, n 87. Full length, (P=O) Total (n-1) 1.2 Total (n+1).54 Total depurination.95 Total TPT ND TCE ND CNET.26 EPD OCH 3 1. n Early eluting species 3.6 Late eluting species 3.3 Molecular weight is ± 1. amu amu S78

47 Table 2. Analysis of 2 -O-methoxyethyl modified phosphorothioate Oligo 2 made using UnyLinker loaded solid support on OligoProcess Sequence: Oligo 2 Results (%) Full length, n 9.2 Full length, (P=O) 1.9 Total (n-1) 2. Total (n+1).3 Total depurination.6 Total TPT ND TCE ND CNET.1 EPD.1 2 -OCH 3.7 n Early eluting species 1. Late eluting species 2.9 Molecular weight is ± 1. amu amu S79

48 Table 3. Comparison of 2 -O-methoxyethyl modified phosphorothioate Oligo 3 made using UnyLinker and MOE mec-nucleoside loaded solid support on OligoProcess Sequence: Oligo 3 PS2- UnyLinker PS2 Baseloaded Full length, n Full length, (P=O) Total (n-1) Total (n+1) ND ND Total depurination.55.4 Total TPT.26.6 TCE ND ND CNET ND ND EPD ND ND 2 -OCH n n Early eluting species Late eluting species Molecular weight is ± 1. amu amu amu S8

49 Table 4. Analysis of 2 -O-methoxyethyl modified phosphorothioate Oligo 4 made using UnyLinker loaded solid support on OligoProcess Sequence: Oligo 4 Results (%) Full length, n 88.5 Full length, (P=O) Total (n-1).94 Total (n+1) ND Total depurination.46 Total TPT ND TCE ND CNET ND EPD ND 2 -OCH 3 1. n Early eluting species 1.4 Late eluting species 3.3 Molecular weight is ± 1. amu amu S81

50 Table 5. Analysis of 2 -O-methoxyethyl modified phosphorothioate Oligo 5 made using UnyLinker loaded solid support on OligoProcess Sequence: Oligo 5 Results (%) Full length, n 87.4 Full length, (P=O) Total (n-1) 1. Total (n+1) ND Total depurination 1.43 Total TPT ND TCE ND CNET.44 EPD ND 2 -OCH n n Early eluting species 2.1 Late eluting species 1.72 Molecular weight is ± 1. amu amu S82

51 Table 6. Analysis of crude 2 -O-methoxyethyl modified phosphorothioate Oligo 6 made using UnyLinker loaded solid support on OligoProcess Sequence: Oligo 6 Results (%) Full length, n 93.7 Full length, (P=O) Total (n-1) 2.8 Total depurination.4 Total TPT.7 TCE.3 CNET.17 EPD.5 2 -OCH 3.5 n + 68 Combined UV area % of two main DMT-on peaks Molecular weight is ± 1. amu amu S83

52 Table 7. Analysis of oligodeoxy phosphorothioate Oligo 7 made using UnyLinker loaded solid support on OligoProcess Sequence: Oligo 7-SYN #1 Results (%) Full length, n 88. Full length, (P=O) Total (n-1) 2.6 Total (n+1).68 Total depurination 2.3 Total TPT.37 TCE ND CNET ND n n n Early eluting species 1.26 Late eluting species 2.11 Molecular weight is ± 1. amu amu S84

53 Table 8. Comparison of oligodeoxy phosphorothioate Oligo 7 made using UnyLinker and da-nucleoside loaded solid supports on OligoProcess Results showing reproducibility of performance of UnyLinker on OligoProcess (Oligo 7-SYN #2 & Oligo 7-SYN #3) Sequence: Oligo 7 SYN #2 Results (%) SYN #3 Results (%) da-loaded Results (%) Full length, n Full length, (P=O) Total (n-1) Total depurination Total TPT.1 ND ND TCE ND ND ND CNET n EPD Molecular weight of DMTon 667 amu amu amu oligo ± 1. amu Combined UV area % of two main DMT-on peaks S85

54 Table 9. Analysis of Oligo 8 using UnyLinker loaded solid support Sequence: Oligo 8 Results (%) Full length, n 89.1 Full length, (P=O) Total (n-1) 2.5 Total (n+1) <.1 Total depurination 1.7 Total TPT <.1 TCE <.1 CNET.27 Total other impurities.37 Early eluting species 2.4 Late eluting species 2.2 Molecular weight is ± 1. amu amu S86

55 Table 1. Analysis of Oligo 9 using UnyLinker loaded solid support Sequence: Oligo 9 Results (%) UV purity n 82.2 n depurination 3.18 n Early eluting species 3.7 Late eluting species 3.28 Molecular weight is ± 1. amu amu S87

56 Table 11. Analysis of 2 -O-methyl modified phosphate/phosphorothioate mixed backbone Oligo 1 using UnyLinker loaded CPG solid support Sequence: Oligo 1 Results (%) UV purity 97.3 n 94.1 P=O.71 (n-1) 2.57 Early eluting species 1.1 Late eluting species 1.56 Molecular weight is ± 1. amu amu S88

57 Table 12. Analysis of 2 -O-methyl modified phosphorothioate Oligo 11 using UnyLinker loaded CPG solid support Sequence: Oligo 11 Results (%) UV purity n 87.5 P=O 3.95 (n-1) 3.36 Early eluting species 1.85 Late eluting species 2.52 Molecular weight is ± 1. amu amu S89

58 Table 13. Analysis of 2 -O-methoxyethyl/RNA modified sequence with phosphate backbone Oligo 12 using UnyLinker loaded CPG solid support Sequence: Oligo 12 Results (%) UV purity 9.93 n 88.9 (n-1) 2.57 Early eluting species 8.41 Late eluting species 1.66 Molecular weight is ± 1. amu amu S9

59 Table 14. Analysis of Oligo 13 using UnyLinker loaded solid support Sequence: Oligo 13 Results (%) UV purity n 91.1 P=O 3.33 (n-1) 1.35 depurination 1.46 Early eluting species 1.8 Late eluting species.74 Molecular weight is ± 1. amu amu S91

60 Table 15. Analysis of Oligo 14 using UnyLinker loaded CPG solid support Sequence: Oligo 14 Results (%) UV purity n 85.1 CNET 6.42 (n-1) 1.3 Unknown 1.6 Early eluting species 4.2 Late eluting species 1.6 Molecular weight is ± 1. amu amu S92

61 Table 16. Analysis of Oligo 15 using UnyLinker loaded solid support Sequence: Oligo 15 Results (%) UV purity 95.9 n P=O 1.85 (n-1) 1.92 Early eluting species 1.36 Late eluting species 2.7 Molecular weight is ± 1. amu amu S93

62 Table 17. Analysis of 2 -O-methoxyethyl/2 -alpha-fluoro modified phosphorothioate Oligo 16 using UnyLinker loaded CPG solid support Sequence: Oligo 16 Results (%) UV purity n P=O 3.81 (n-1) 1.36 Unknown 1.1 Early eluting species 7.97 Late eluting species 2.58 Molecular weight is ± 1. amu amu S94

63 Table 18. Analysis of Oligo 17 using UnyLinker loaded CPG solid support Sequence: Oligo 17 Results (%) UV purity 89.8 n 8.89 P=O 2.2 (n-1) 5.4 Early eluting species 5.73 Late eluting species 4.45 Molecular weight is ± 1. amu amu S95

64 Table 19. Analysis of Oligo 18 using UnyLinker loaded CPG solid support Sequence: Oligo 18 Results (%) UV purity n P=O 1.7 (n-1) 1.88 Early eluting species.62 Late eluting species.59 Molecular weight is ± 1. amu amu S96

65 Table 2. Analysis of 2 -deoxy/lna modified phosphorothioate Oligo 19 using UnyLinker loaded CPG solid support Sequence: Oligo 19 Results (%) UV purity n P=O.42 (n-1) 1.42 Total unknowns 4.94 Early eluting species 2.58 Late eluting species 1.7 Molecular weight is ± 1. amu amu S97

66 Table 21. Analysis of 2 -deoxy/lna modified phosphate/phosphorothioate mixed backbone Oligo 2 using UnyLinker loaded CPG solid support Sequence: Oligo 2 Results (%) UV purity n depurination.67 (n-1) 3.36 unknown.43 Early eluting species 5.58 Late eluting species 1.13 Molecular weight is ± 1. amu amu S98

67 Table 22. Analysis of Oligo 21 using UnyLinker loaded CPG solid support Sequence: Oligo 21 Results (%) UV purity n P=O 1.51 (n-1) 2.22 Early eluting species.95 Late eluting species.71 Molecular weight is ± 1. amu amu S99

68 Table 23. Analysis of 2 -deoxy/lna modified phosphorothioate Oligo 22 using UnyLinker loaded CPG solid support Sequence: Oligo 22 Results (%) UV purity n 93.6 P=O 2.11 (n-1) 1.19 Unknown 1.1 Early eluting species 1.65 Late eluting species 1.45 Molecular weight is ± 1. amu amu S1

69 Table 24. Analysis of Oligo 23 using UnyLinker loaded CPG solid support Sequence: Oligo 23 Results (%) UV purity n P=O 2.1 (n-1).95 Early eluting species 1.41 Late eluting species 1.32 Molecular weight is ± 1. amu amu S11

70 Table 25. Analysis of Oligo 24 using UnyLinker loaded CPG solid support Sequence: Oligo 24 Results (%) UV purity n 9.78 P=O 1.93 (n-1) 1.26 Early eluting species 2.23 Late eluting species 1.21 Molecular weight is ± 1. amu amu S12

71 Table 26. Analysis of Oligo 25 using UnyLinker loaded CPG solid support Sequence: Oligo 25 Results (%) UV purity 95.7 n 9.68 P=O.27 (n-1) 1.18 depurination 2.9 Early eluting species 1.26 Late eluting species 3.4 Molecular weight is ± 1. amu amu S13

72 Table 27. Analysis of 2 -deoxy/lna modified phosphorothioate Oligo 26 using UnyLinker loaded CPG solid support Sequence: Oligo 26 Results (%) UV purity 94.1 n 89.1 P=O 1.55 (n-1).6 Unknown 2.29 Early eluting species 3.17 Late eluting species 2.73 Molecular weight is ± 1. amu amu S14

73 Table 28. Analysis of Oligo 27 using UnyLinker loaded solid support Sequence: Oligo 27 Results (%) UV purity 9.2 n 86.5 P=O 3.7 (n-1) 1.9 CNET.33 Early eluting species 3.5 Late eluting species 2.2 Molecular weight is 682. ± 1.2 amu amu S15

74 Table 29. Analysis of Oligo 28 using UnyLinker loaded CPG solid support Sequence: Oligo 28 Results (%) UV purity 95.9 n 93.2 P=O 1.33 (n-1).83 Early eluting species.96 Late eluting species 3.14 Molecular weight is ± 1. amu amu S16

75 Table 3. Analysis of Oligo 29 using UnyLinker loaded CPG solid support Sequence: Oligo 29 Results (%) UV purity 95.6 n P=O 2.23 (n-1) 2.84 Early eluting species.95 Late eluting species 3.46 Molecular weight is ± 1. amu amu S17

76 Table 31. Analysis of Oligo 3 using UnyLinker loaded CPG solid support Sequence: Oligo 3 Results (%) UV purity n P=O 3.81 (n+187) 1.1 Early eluting species 7.96 Late eluting species 2.58 Molecular weight is ± 1. amu amu S18

77 Table 32. Analysis of Oligo 31 using UnyLinker loaded CPG solid support Sequence: Oligo 31 Results (%) UV purity 9.6 n P=O 3.54 Early eluting species 8.5 Late eluting species 1.89 Molecular weight is ± 1. amu amu S19

78 Table 33. Analysis of Oligo 32 using UnyLinker loaded CPG solid support Sequence: Oligo 32 Results (%) UV purity n 77.3 CNET 3.22 (n+methyl).77 (n-1) 1.26 Early eluting species 1.29 Late eluting species.8 Molecular weight is ± 1. amu amu S11

79 Table 34. Analysis of Oligo 33 using UnyLinker loaded CPG solid support Sequence: Oligo 33 Results (%) UV purity n 85.2 n + methyl 5.1 (n-1) 2.75 Early eluting species 5.31 Late eluting species.87 Molecular weight is ± 1. amu amu S111

80 Table 35. Analysis of Oligo 34 using UnyLinker loaded CPG solid support Sequence: Oligo 34 Results (%) UV purity n 7.52 (n-1) 2.59 (n+methyl) 3.29 n Early eluting species Late eluting species 1.37 Molecular weight is ± 1. amu amu S112

81 Table 36. Analysis of Oligo 35 using UnyLinker loaded CPG solid support Sequence: Oligo 35 Results (%) UV purity n 9.78 P=O.3 (n-1) 1.88 n + methyl 2.46 Early eluting species 3.73 Late eluting species 1.49 Molecular weight is ± 1. amu amu S113

82 Table 37. Analysis of Oligo 36 using UnyLinker loaded CPG solid support Sequence: Oligo 36 Results (%) UV purity n 57.8 P=O 1.78 (n-1) 1.98 n + methyl 5.48 Early eluting species Late eluting species.13 Molecular weight is ± 1. amu amu S114

83 Table 38. Comparison of 2 -O-methoxyethyl modified phosphorothioate Oligo 37 made using UnyLinker and MOE mec-nucleoside loaded solid supports on 96-well plate MerMade (Bioautomation) synthesizer (Synthesis #1) Control #1 Control #2 UnyLinker Syn #1 UnyLinker Syn #2 UnyLinker Syn #3 mass % % % % % Full length P=O TPT n-t n-moe mec/moe meu Total S115

84 Table 39. Comparison of 2 -O-methoxyethyl modified phosphorothioate Oligo 37 made using UnyLinker and MOE mec-nucleoside loaded solid supports on 96-well plate MerMade (Bioautomation) synthesizer (Synthesis #2). Results showing reproducibility of performance of UnyLinker loaded on CPG Control Syn #1 Control Syn #2 Control Syn #3 Control Syn #4 UnyLinker Syn #1 UnyLinker Syn #2 UnyLinker Syn #3 UnyLinker Syn #4 % % % % % % % % Full length P=O TPT n-t n-moe mec /MOE meu shortmer full length longmer S116

85 Table 4. Crystal data and structure refinement for iris. Identification code iris Empirical formula C14 H13 N O5 Formula weight Temperature 298(2) K Wavelength.7173 Å Crystal system Monoclinic Space group P2(1)/c Unit cell dimensions a = (3) Å = 9. b = (1) Å = 92.35(13). c = (2) Å = 9. Volume 125.1(4) Å 3 Z 4 Density (calculated) Mg/m 3 Absorption coefficient.117 mm -1 F() 576 Crystal size.14 x.5 x.2 mm 3 Theta range for data collection 2.4 to Index ranges -2<=h<=2, -1<=k<=7, -14<=l<=4 Reflections collected 3555 Independent reflections 2124 [R(int) =.327] Completeness to theta = % Absorption correction None Refinement method Full-matrix least-squares on F 2 Data / restraints / parameters 2124 / / 234 Goodness-of-fit on F Final R indices [I>2sigma(I)] R1 =.393, wr2 =.993 R indices (all data) R1 =.583, wr2 =.1186 Extinction coefficient.9(2) Largest diff. peak and hole.21 and -.24 e.å -3 S117

86 Table 41. Atomic coordinates ( x 14) and equivalent isotropic displacement parameters (Å2x 13) for iris. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. x y z U(eq) N(1) 2983(1) 1984(3) 6112(1) 34(1) O(1) 457(1) -2145(3) 367(2) 51(1) O(2) -14(1) 289(3) 3527(1) 48(1) O(3) 2276(1) 5185(3) 6411(1) 44(1) O(4) 3428(1) -1347(3) 5427(1) 49(1) O(5) 1179(1) 471(2) 543(1) 34(1) C(1) 187(1) -636(4) 3574(2) 41(1) C(2) 812(1) 1851(4) 3645(2) 41(1) C(3) 1152(1) 2542(4) 486(2) 35(1) C(4) 231(1) 2978(4) 4714(2) 34(1) C(5) 2422(1) 36(3) 5831(2) 33(1) C(6) 2988(1) 224(4) 5358(2) 35(1) C(7) 2349(1) 647(4) 4468(2) 35(1) C(8) 1611(1) -82(4) 4633(2) 35(1) C(9) 352(1) 2125(3) 795(2) 33(1) C(1) 3529(1) 382(4) 7853(2) 41(1) C(11) 427(1) 555(4) 881(2) 48(1) C(12) 4485(1) 2423(5) 8967(2) 51(1) C(13) 4456(1) 4141(4) 82(2) 47(1) C(14) 396(1) 44(4) 7255(2) 39(1) S118

87 Table 42. Bond lengths [Å] and angles [ ] for iris. N(1)-C(6) 1.382(3) N(1)-C(5) 1.388(3) N(1)-C(9) 1.437(3) O(1)-C(1) 1.47(3) O(1)-H(1A).94(4) O(2)-C(2) 1.412(3) O(2)-H(2A).92(4) O(3)-C(5) 1.22(2) O(4)-C(6) 1.2(2) O(5)-C(8) 1.439(2) O(5)-C(3) 1.442(2) C(1)-C(8) 1.515(3) C(1)-C(2) 1.56(3) C(1)-H(2B).97(2) C(2)-C(3) 1.532(3) C(2)-H(1B).96(2) C(3)-C(4) 1.525(3) C(3)-H(3A).98(2) C(4)-C(5) 1.57(3) C(4)-C(7) 1.525(3) C(4)-H(4A).94(2) C(6)-C(7) 1.56(3) C(7)-C(8) 1.542(3) C(7)-H(6A).96(2) C(8)-H(8A).97(2) C(9)-C(14) 1.373(3) C(9)-C(1) 1.376(3) C(1)-C(11) 1.385(3) C(1)-H(7A).97(3) C(11)-C(12) 1.37(4) C(11)-H(11A).95(2) C(12)-C(13) 1.372(4) C(12)-H(12A).96(3) C(13)-C(14) 1.38(3) C(13)-H(13A) 1.1(3) S119

88 C(14)-H(9A).96(2) C(6)-N(1)-C(5) (16) C(6)-N(1)-C(9) 123.6(16) C(5)-N(1)-C(9) 123.2(17) C(1)-O(1)-H(1A) 16(2) C(2)-O(2)-H(2A) 15(2) C(8)-O(5)-C(3) 96.9(15) O(1)-C(1)-C(8) 18.29(18) O(1)-C(1)-C(2) 112.1(18) C(8)-C(1)-C(2) 1.62(17) O(1)-C(1)-H(2B) 111.5(13) C(8)-C(1)-H(2B) 112.2(13) C(2)-C(1)-H(2B) 111.8(14) O(2)-C(2)-C(3) (18) O(2)-C(2)-C(1) (18) C(3)-C(2)-C(1) 11.66(17) O(2)-C(2)-H(1B) 16.8(11) C(3)-C(2)-H(1B) 11.(11) C(1)-C(2)-H(1B) 112.2(11) O(5)-C(3)-C(4) 99.91(16) O(5)-C(3)-C(2) 13.69(17) C(4)-C(3)-C(2) 18.37(17) O(5)-C(3)-H(3A) 19.5(13) C(4)-C(3)-H(3A) 117.2(13) C(2)-C(3)-H(3A) 116.1(12) C(5)-C(4)-C(3) 112.6(17) C(5)-C(4)-C(7) 14.36(16) C(3)-C(4)-C(7) 12.31(17) C(5)-C(4)-H(4A) 11.9(13) C(3)-C(4)-H(4A) 112.3(13) C(7)-C(4)-H(4A) 114.4(13) O(3)-C(5)-N(1) (18) O(3)-C(5)-C(4) (18) N(1)-C(5)-C(4) 18.32(17) O(4)-C(6)-N(1) 124.7(19) O(4)-C(6)-C(7) 127.5(2) S12

89 N(1)-C(6)-C(7) 17.84(17) C(6)-C(7)-C(4) 15.55(17) C(6)-C(7)-C(8) (18) C(4)-C(7)-C(8) 11.2(16) C(6)-C(7)-H(6A) 11.1(12) C(4)-C(7)-H(6A) 117.3(13) C(8)-C(7)-H(6A) 11.2(13) O(5)-C(8)-C(1) 12.46(16) O(5)-C(8)-C(7) 13.11(16) C(1)-C(8)-C(7) 18.7(17) O(5)-C(8)-H(8A) 19.(14) C(1)-C(8)-H(8A) 117.1(13) C(7)-C(8)-H(8A) 115.4(13) C(14)-C(9)-C(1) 121.5(2) C(14)-C(9)-N(1) 119.4(18) C(1)-C(9)-N(1) (19) C(9)-C(1)-C(11) 118.7(2) C(9)-C(1)-H(7A) 118.7(14) C(11)-C(1)-H(7A) 122.5(14) C(12)-C(11)-C(1) 12.2(2) C(12)-C(11)-H(11A) 12.8(14) C(1)-C(11)-H(11A) 119.1(14) C(11)-C(12)-C(13) 12.5(2) C(11)-C(12)-H(12A) 12.3(17) C(13)-C(12)-H(12A) 119.3(17) C(12)-C(13)-C(14) 12.1(2) C(12)-C(13)-H(13A) 118.7(17) C(14)-C(13)-H(13A) 121.1(17) C(9)-C(14)-C(13) 119.(2) C(9)-C(14)-H(9A) 12.7(14) C(13)-C(14)-H(9A) 12.3(14) Symmetry transformations used to generate equivalent atoms: S121

90 Table 43. Anisotropic displacement parameters (Å2x 13) for iris. The anisotropic displacement factor exponent takes the form: -22[ h2 a*2u h k a* b* U12 ] U 11 U 22 U 33 U 23 U 13 U 12 N(1) 29(1) 35(1) 37(1) -1(1) -5(1) 3(1) O(1) 45(1) 56(1) 51(1) -6(1) -9(1) -16(1) O(2) 31(1) 58(1) 54(1) 18(1) -13(1) -4(1) O(3) 42(1) 39(1) 49(1) -6(1) -5(1) 8(1) O(4) 41(1) 43(1) 61(1) -5(1) -3(1) 14(1) O(5) 32(1) 37(1) 32(1) 5(1) -2(1) (1) C(1) 37(1) 52(1) 36(1) -2(1) -1(1) -5(1) C(2) 31(1) 52(1) 4(1) 13(1) -3(1) -6(1) C(3) 29(1) 36(1) 4(1) 5(1) -4(1) 1(1) C(4) 3(1) 35(1) 36(1) 5(1) -1(1) -1(1) C(5) 27(1) 32(1) 4(1) 4(1) (1) -1(1) C(6) 27(1) 37(1) 41(1) 1(1) 1(1) 1(1) C(7) 31(1) 4(1) 34(1) -3(1) -1(1) 2(1) C(8) 36(1) 32(1) 37(1) -2(1) -3(1) 1(1) C(9) 24(1) 39(1) 36(1) (1) (1) 3(1) C(1) 36(1) 41(1) 48(1) 5(1) 2(1) 2(1) C(11) 49(1) 56(2) 4(1) 12(1) (1) 15(1) C(12) 42(1) 68(2) 41(1) -5(1) -9(1) 1(1) C(13) 37(1) 54(2) 48(1) -7(1) -5(1) -3(1) C(14) 35(1) 41(1) 41(1) 2(1) -1(1) -1(1) S122

91 Table 44. Hydrogen coordinates ( x 14) and isotropic displacement parameters (Å2x 1 3) for iris. x y z U(eq) H(1B) 134(11) 277(3) 371(16) 22(5) H(2B) 1375(13) -92(4) 29(2) 41(6) H(4A) 2135(12) 46(4) 4165(19) 35(6) H(3A) 848(13) 365(4) 521(18) 37(6) H(11A) 439(13) -63(4) 934(2) 42(6) H(6A) 2547(12) 39(4) 3735(19) 36(6) H(7A) 322(14) -95(4) 768(2) 48(7) H(8A) 1711(13) -229(4) 4936(19) 42(6) H(9A) 3921(13) 523(4) 674(2) 44(6) H(12A) 4828(16) 255(4) 962(2) 64(8) H(13A) 479(17) 552(5) 836(2) 74(9) H(1A) 278(19) -249(6) 293(3) 96(11) H(2A) -22(2) 94(6) 395(3) 12(12) S123

92 Table 45. Torsion angles [ ] for iris. O(1)-C(1)-C(2)-O(2) -13.7(3) C(8)-C(1)-C(2)-O(2) (19) O(1)-C(1)-C(2)-C(3) 18.19(19) C(8)-C(1)-C(2)-C(3) -6.66(19) C(8)-O(5)-C(3)-C(4) (17) C(8)-O(5)-C(3)-C(2) 52.91(17) O(2)-C(2)-C(3)-O(5) 93.5(2) C(1)-C(2)-C(3)-O(5) -28.3(19) O(2)-C(2)-C(3)-C(4) (18) C(1)-C(2)-C(3)-C(4) 77.5(2) O(5)-C(3)-C(4)-C(5) -7.1(2) C(2)-C(3)-C(4)-C(5) (18) O(5)-C(3)-C(4)-C(7) 41.18(19) C(2)-C(3)-C(4)-C(7) -66.9(2) C(6)-N(1)-C(5)-O(3) (19) C(9)-N(1)-C(5)-O(3) -5.3(3) C(6)-N(1)-C(5)-C(4) -4.5(2) C(9)-N(1)-C(5)-C(4) 176.(17) C(3)-C(4)-C(5)-O(3) -6.8(3) C(7)-C(4)-C(5)-O(3) -17.8(2) C(3)-C(4)-C(5)-N(1) (18) C(7)-C(4)-C(5)-N(1) 7.9(2) C(5)-N(1)-C(6)-O(4) 179.2(2) C(9)-N(1)-C(6)-O(4) -1.2(3) C(5)-N(1)-C(6)-C(7) -1.1(2) C(9)-N(1)-C(6)-C(7) 178.4(18) O(4)-C(6)-C(7)-C(4) (2) N(1)-C(6)-C(7)-C(4) 6.1(2) O(4)-C(6)-C(7)-C(8) 76.5(3) N(1)-C(6)-C(7)-C(8) -13.1(2) C(5)-C(4)-C(7)-C(6) -8.3(2) C(3)-C(4)-C(7)-C(6) (17) C(5)-C(4)-C(7)-C(8) 18.94(17) C(3)-C(4)-C(7)-C(8) -7.97(19) C(3)-O(5)-C(8)-C(1) (18) S124

93 C(3)-O(5)-C(8)-C(7) 54.3(17) O(1)-C(1)-C(8)-O(5) -78.(2) C(2)-C(1)-C(8)-O(5) 39.6(19) O(1)-C(1)-C(8)-C(7) (17) C(2)-C(1)-C(8)-C(7) -68.8(2) C(6)-C(7)-C(8)-O(5) 84.3(2) C(4)-C(7)-C(8)-O(5) (19) C(6)-C(7)-C(8)-C(1) (18) C(4)-C(7)-C(8)-C(1) 8.2(2) C(6)-N(1)-C(9)-C(14) 125.6(2) C(5)-N(1)-C(9)-C(14) -54.9(3) C(6)-N(1)-C(9)-C(1) -54.4(3) C(5)-N(1)-C(9)-C(1) 125.1(2) C(14)-C(9)-C(1)-C(11).6(3) N(1)-C(9)-C(1)-C(11) (19) C(9)-C(1)-C(11)-C(12) -.6(3) C(1)-C(11)-C(12)-C(13).1(4) C(11)-C(12)-C(13)-C(14).3(4) C(1)-C(9)-C(14)-C(13) -.2(3) N(1)-C(9)-C(14)-C(13) (19) C(12)-C(13)-C(14)-C(9) -.3(3) Symmetry transformations used to generate equivalent atoms: S125

94 O HO HO Hc 9 8 Hb O 2 Ha 6 O N Showing C8---C7 bonding O C 9 OH H b H C C 6 o Showing C7---C6 bonding C 5 C 8 O H a H b C 2 o S126

Supplementary Information

Supplementary Information Electronic Supplementary Material (ESI) for ChemComm. This journal is The Royal Society of Chemistry 2018 Supplementary Information Oxidative Tandem Annulation of 1 (2 Ethynylaryl)prop 2 en 1 ones Catalyzed

More information

Copper(II) Ionic Liquid Catalyzed Cyclization-Aromatization of. Hydrazones with Dimethyl Acetylenedicarboxylate: A Green Synthesis

Copper(II) Ionic Liquid Catalyzed Cyclization-Aromatization of. Hydrazones with Dimethyl Acetylenedicarboxylate: A Green Synthesis Copper(II) Ionic Liquid Catalyzed Cyclization-Aromatization of Hydrazones with Dimethyl Acetylenedicarboxylate: A Green Synthesis of Fully Substituted Pyrazoles Shirin Safaei, Iraj Mohammadpoor-Baltork,*

More information

Zn 2+ Triggered Amide Tautomerization Produces a Highly Zn 2+ Selective, Cell Permeable and Ratiometric Fluorescent Sensor

Zn 2+ Triggered Amide Tautomerization Produces a Highly Zn 2+ Selective, Cell Permeable and Ratiometric Fluorescent Sensor Supporting Information For Zn 2+ Triggered Amide Tautomerization Produces a Highly Zn 2+ Selective, Cell Permeable and Ratiometric Fluorescent Sensor Zhaochao Xu,*,, Kyung-Hwa Baek, Ha Na Kim, Jingnan

More information

b = (17) Å c = (18) Å = (4) = (4) = (4) V = (3) Å 3 Data collection Refinement

b = (17) Å c = (18) Å = (4) = (4) = (4) V = (3) Å 3 Data collection Refinement organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 (Z)-N-tert-Butyl-2-(4-methoxyanilino)- N 0 -(4-methoxyphenyl)-2-phenylacetimidamide Sue A. Roberts, a * Biswajit

More information

Experimental. Crystal data. C 19 H 19 N 3 O 3 M r = Monoclinic, C2=c a = (3) Å b = (2) Å c = (3) Å = 110.

Experimental. Crystal data. C 19 H 19 N 3 O 3 M r = Monoclinic, C2=c a = (3) Å b = (2) Å c = (3) Å = 110. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 A second monoclinic polymorph of 4-(2- hydroxy-4-methoxybenzylideneamino)- 1,5-dimethyl-2-phenyl-1H-pyrazol- 3(2H)-one

More information

Experimental. Crystal data. C 20 H 23 N 4 O 6 PS M r = Monoclinic, P2 1 =n a = (2) Å b = (4) Å c = (2) Å = 117.

Experimental. Crystal data. C 20 H 23 N 4 O 6 PS M r = Monoclinic, P2 1 =n a = (2) Å b = (4) Å c = (2) Å = 117. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Diethyl {(4-methoxyphenyl)[5-(4-nitro- phenyl)-1,3,4-thiadiazol-2-ylamino]- methyl}phosphonate Li-He Yin, Rong

More information

Data collection. Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 326 parameters 2 restraints

Data collection. Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 326 parameters 2 restraints organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 2-Chloro-N-(2,3-dichlorophenyl)- benzamide B. Thimme Gowda, a * Sabine Foro, b B. P. Sowmya a and Hartmut Fuess

More information

organic compounds (E)-Ethyl N 0 -(3-hydroxybenzylidene)- hydrazinecarboxylate dihydrate

organic compounds (E)-Ethyl N 0 -(3-hydroxybenzylidene)- hydrazinecarboxylate dihydrate organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 (E)-Ethyl N 0 -(3-hydroxybenzylidene)- hydrazinecarboxylate dihydrate Xian-Chao Hu, a,b * Jie Zhang, a Da-Yong

More information

Experimental. Crystal data. C 12 H 20 N 4 O M r = Orthorhombic, P a = (3) Å b = (4) Å c = 14.

Experimental. Crystal data. C 12 H 20 N 4 O M r = Orthorhombic, P a = (3) Å b = (4) Å c = 14. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 5-[(1R,2R,4R)-2-Methoxy-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl]-1H-tetrazole Jan W. Bats,* Peter Schell and Joachim

More information

X-ray crystallographic analysis of 72 Data collection A colorless prism crystal of C Br 4 having approximate dimensions of mm was

X-ray crystallographic analysis of 72 Data collection A colorless prism crystal of C Br 4 having approximate dimensions of mm was Total synthesis of cortistatins A and J Shuji Yamashita, *,a Kentaro Iso, a Kazuki Kitajima, a Masafumi imuro, a and Masahiro irama *,a, b a Department of Chemistry, Graduate School of Science, Tohoku

More information

metal-organic compounds

metal-organic compounds metal-organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 (Benzoato-j 2 O,O 0 )(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-j 4 N,N 0,N 00,N 000 )nickel(ii)

More information

Highly efficient hydrazination of conjugated nitroalkenes via imidazole or DMAP mediated Morita-Baylis-Hillman reaction

Highly efficient hydrazination of conjugated nitroalkenes via imidazole or DMAP mediated Morita-Baylis-Hillman reaction Experimental Data and ptimization Tables For Highly efficient hydrazination of conjugated nitroalkenes via imidazole or DMAP mediated Morita-Baylis-Hillman reaction M. Dadwal, S. M. Mobin, I... amboothiri

More information

Experimental. Crystal data

Experimental. Crystal data organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 4-Bromo-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-5-(4-methoxybenzylideneamino)-1H-pyrazole-3-carbonitrile Guohui

More information

Experimental. Crystal data. C 32 H 25 NO 5 M r = Monoclinic, C2=c a = (6) Å b = (2) Å c = (3) Å = 96.

Experimental. Crystal data. C 32 H 25 NO 5 M r = Monoclinic, C2=c a = (6) Å b = (2) Å c = (3) Å = 96. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Methyl 9-hydroxy-15-methyl-2-oxo-11- (pyren-1-yl)-10-oxa-15-azatetracyclo- [7.6.0.0 1,12.0 3,8 ]pentadeca-3(8),4,6-

More information

Experimental. Crystal data. C 22 H 26 N 2 O 3 M r = Triclinic, P1 a = (3) Å b = (4) Å c = (4) Å = (6) = 100.

Experimental. Crystal data. C 22 H 26 N 2 O 3 M r = Triclinic, P1 a = (3) Å b = (4) Å c = (4) Å = (6) = 100. Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 15-Methoxy-14,15-dihydroandranginine Dian-Lei Wang, a Xiang-Hai Cai, b Peng Huang a * and He-Ping Huang a * a School of Pharmacy,

More information

metal-organic compounds

metal-organic compounds metal-organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 4-(4-Pyridyl)pyridinium bis(pyridine-2,6- dicarboxylato)chromium(iii) tetrahydrate Janet Soleimannejad,

More information

data reports 11b-Hydroxymedroxyprogesterone Structure description

data reports 11b-Hydroxymedroxyprogesterone Structure description 11b-Hydroxymedroxyprogesterone ISSN 2414-3146 Sharifah Nurfazilah Wan Yusop, a,b Sadia Sultan, a,b Bohari M. Yamin, c Syed Adnan Ali Shah a,b and Humera Naz a,b * Received 30 May 2016 Accepted 4 July 2016

More information

2-Methyl-4-nitro-1-(4-nitrophenyl)-1H-imidazole

2-Methyl-4-nitro-1-(4-nitrophenyl)-1H-imidazole University of Wollongong Research Online Australian Institute for Innovative Materials - Papers Australian Institute for Innovative Materials 2007 2-Methyl-4-nitro-1-(4-nitrophenyl)-1H-imidazole Pawel

More information

organic papers 4-Methylpyridinium bis(pyrocatecholato-j 2 O,O 0 )- borate catechol solvate

organic papers 4-Methylpyridinium bis(pyrocatecholato-j 2 O,O 0 )- borate catechol solvate organic papers Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 4-Methylpyridinium bis(pyrocatecholato-j 2 O,O 0 )- borate catechol solvate R. Angharad Baber, Jonathan P. H. Charmant,*

More information

metal-organic compounds

metal-organic compounds metal-organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Chlorido(2-chloronicotinato)triphenylantimony(V) Li Quan, Handong Yin* and Daqi Wang College of Chemistry

More information

Thermotropic liquid crystals based on 1,8,9,16-tetrasubstituted tetraphenylenes and their structure-property relationship studies

Thermotropic liquid crystals based on 1,8,9,16-tetrasubstituted tetraphenylenes and their structure-property relationship studies Supporting Information Thermotropic liquid crystals based on 1,8,9,16-tetrasubstituted tetraphenylenes and their structure-property relationship studies Chun-Kit Hau a, b, c, Stephen Sin-Yin Chui d, Wei

More information

Data collection. Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 315 parameters

Data collection. Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 315 parameters organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 N-(2,4,5-Trichlorophenyl)maleamic acid B. Thimme Gowda, a * Miroslav Tokarčík, b Jozef Kožíšek, b K. Shakuntala

More information

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010) June 2010 TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010) This monograph was adopted at the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical

More information

Experimental. Crystal data. C 23 H 20 N 2 O 2 M r = Monoclinic, P2 1 =c a = (3) Å b = (1) Å c = (2) Å = 91.

Experimental. Crystal data. C 23 H 20 N 2 O 2 M r = Monoclinic, P2 1 =c a = (3) Å b = (1) Å c = (2) Å = 91. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 8-Benzyloxy-2-methyl-3-(2-methylphenyl)quinazolin-4(3H)-one Adel S. El-Azab, a,b Alaa A.-M. Abdel-Aziz, a,c Seik

More information

data reports cis-cyclohexane-1,3-dicarboxylic acid N,N 0 -(pentane-1,5-diyl)bis(pyridine-4-carboxamide) water (1/1/2) Structure description

data reports cis-cyclohexane-1,3-dicarboxylic acid N,N 0 -(pentane-1,5-diyl)bis(pyridine-4-carboxamide) water (1/1/2) Structure description ISSN 2414-3146 cis-cyclohexane-1,3-dicarboxylic acid N,N 0 -(pentane-1,5-diyl)bis(pyridine-4-carboxamide) water (1/1/2) Brianna L. Martinez and Robert L. LaDuca* Received 23 September 2017 Accepted 12

More information

Experimental. Crystal data

Experimental. Crystal data organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 N,N 0 -(Biphenyl-2,2 0 -diyl)bis(furan-2- carboxamide) Chin Hui Kee, Noel F. Thomas, Azhar Ariffin, Khalijah Awang

More information

Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 385 parameters

Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 385 parameters organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 3a,6a-Bis(ethoxycarbonyl)glycoluril (diethyl 2,5-dioxoperhydroimidazo- [4,5-d]imidazole-3a,6a-dicarboxylate) Yu-Zhou

More information

This is an electronic reprint of the original article. This reprint may differ from the original in pagination and typographic detail.

This is an electronic reprint of the original article. This reprint may differ from the original in pagination and typographic detail. This is an electronic reprint of the original article. This reprint may differ from the original in pagination and typographic detail. Author(s): Salorinne, Kirsi; Tero, Tiia-Riikka; Lahtinen, Tanja Title:

More information

Experimental. Crystal data

Experimental. Crystal data organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Bis[8-ethyl-5-oxo-2-(piperazin-4-ium-1- yl)-5,8-dihydropyrido[2,3-d]pyrimidine- 6-carboxylic acid] 2,5-dicarboxybenzene-1,4-dicarboxylate

More information

2. Experimental Crystal data

2. Experimental Crystal data data reports ISSN 2056-9890 Crystal structure of (tert-butyldimethylsilyl)triphenylgermane, Ph 3 Ge-SiMe 2 (t-bu) Kirill V. Zaitsev, a Galina S. Zaitseva, a Sergey S. Karlov a * and Alexander A. Korlyukov

More information

metal-organic compounds

metal-organic compounds metal-organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 catena-poly[{di-l-isonicotinato-bis- [diaquaisonicotinatoeuropium(iii)]}-l- isonicotinato-[diisonicotinatocopper(ii)]-

More information

High-Throughput Analysis of Oligonucleotides using Automated Electrospray Ionization Mass Spectrometry

High-Throughput Analysis of Oligonucleotides using Automated Electrospray Ionization Mass Spectrometry High-Throughput Analysis of Oligonucleotides using Automated Electrospray Ionization Mass Spectrometry Mark E. Hail 1, Brian Elliott 2, Kerry Nugent 3, Jeffrey L. Whitney 1, and David J. Detlefsen 1 1

More information

metal-organic compounds

metal-organic compounds metal-organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Bis{3-amino-1-carbamothioyl-5-[(2-{[(5- methyl-1h-imidazol-3-ium-4-yl)methyl]- sulfanyl}ethyl)amino]-1h-1,2,4-triazol-4-

More information

= (3) = (3) = (4) V = (4) Å 3 Z =2. Data collection. Refinement

= (3) = (3) = (4) V = (4) Å 3 Z =2. Data collection. Refinement organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 = 95.181 (3) = 112.830 (3) = 106.243 (4) V = 948.7 (4) Å 3 Z =2 Mo K radiation = 0.07 mm 1 T = 298 (2) K 0.41

More information

Experimental. Crystal data. C 20 H 26 O 4 M r = Orthorhombic, P a = (1) Å b = (2) Å c = 13.

Experimental. Crystal data. C 20 H 26 O 4 M r = Orthorhombic, P a = (1) Å b = (2) Å c = 13. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Redetermination and absolute configuration of 6-hydroxysalvinolone Hoong-Kun Fun, a * Ching Kheng Quah a and Suchada

More information

metal-organic compounds

metal-organic compounds metal-organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Diaquabis{4-[(pyridin-2-yl)methylideneamino]benzenesulfonato-j 2 N,N 0 }- nickel(ii) tetrahydrate Chao-Zhu

More information

Aeris. Precision Engineered Core- Shell Particles for Ultra-High Resolution BioSeparations. Aeris PEPTIDE. Aeris WIDEPORE

Aeris. Precision Engineered Core- Shell Particles for Ultra-High Resolution BioSeparations. Aeris PEPTIDE. Aeris WIDEPORE Aeris Precision Engineered Core- Shell Particles for Ultra-High Resolution BioSeparations Aeris is a specialized line of reversed phase core-shell UHPLC columns, built exclusively for the ultra-high performance

More information

Experimental. Crystal data. C 23 H 34 O 4 M r = Orthorhombic, P a = (6) Å b = (4) Å c = 18.

Experimental. Crystal data. C 23 H 34 O 4 M r = Orthorhombic, P a = (6) Å b = (4) Å c = 18. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 3b-Acetoxy-19-hydroxy-D 5 -pregnen-20- one Aike Meier zu Greffen, Darius P. Kranz, Jörg-M. Neudörfl and Hans-Günther

More information

Sulfate Radical-Mediated Degradation of Sulfadiazine by CuFeO 2 Rhombohedral Crystal-Catalyzed Peroxymonosulfate: Synergistic Effects and Mechanisms

Sulfate Radical-Mediated Degradation of Sulfadiazine by CuFeO 2 Rhombohedral Crystal-Catalyzed Peroxymonosulfate: Synergistic Effects and Mechanisms Supporting Information for Sulfate Radical-Mediated Degradation of Sulfadiazine by CuFeO 2 Rhombohedral Crystal-Catalyzed Peroxymonosulfate: Synergistic Effects and Mechanisms Submitted by Yong Feng, Deli

More information

2. Experimental Crystal data

2. Experimental Crystal data data reports Metal-organic coordination complexes of N,N 0 -bis(salicylidene)ethylenediamine (salen) Schiff-base derivatives have been studied extensively within the fields of homogeneous catalysis (Wezenberg

More information

addenda and errata 5,17-Di-tert-butyl-25,27-dihydroxycalix[4]arene. Erratum

addenda and errata 5,17-Di-tert-butyl-25,27-dihydroxycalix[4]arene. Erratum addenda and errata Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 5,17-Di-tert-butyl-25,27-dihydroxycalix[4]arene. Erratum Jeffrey C. Bryan,* Richard A. Sachleben and Agathe Urvoas

More information

metal-organic compounds

metal-organic compounds metal-organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 2-(2-Pyridyl)pyridinium bis(pyridine-2,6- dicarboxylato-j 3 O,N,O 0 )aluminate(iii) trihydrate Janet Soleimannejad,

More information

Supporting Information to Sulfate templated assembly of neutral receptors in aqueous DMSO orthogonal versus biplane structures

Supporting Information to Sulfate templated assembly of neutral receptors in aqueous DMSO orthogonal versus biplane structures Supporting Information to Sulfate templated assembly of neutral receptors in aqueous DMS orthogonal versus biplane structures Krzysztof Bąk, Michał J. Chmielewski,* 1. Synthesis and characterisation of

More information

b = (10) Å c = (3) Å V = (3) Å 3 Z =4 Data collection Refinement

b = (10) Å c = (3) Å V = (3) Å 3 Z =4 Data collection Refinement organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 N-(Fluoren-9-ylmethoxycarbonyl)-Laspartic acid 4-tert-butyl ester Kazuhiko Yamada, a * Daisuke Hashizume b and

More information

Z =2 Mo K radiation = 0.11 mm 1. Data collection. Refinement

Z =2 Mo K radiation = 0.11 mm 1. Data collection. Refinement organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 N 0 -[(E)-4-Benzyloxy-2-hydroxybenzylidene]-4-nitrobenzohydrazide monohydrate Bibitha Joseph, a M. Sithambaresan

More information

metal-organic compounds

metal-organic compounds metal-organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 catena-poly[[bis[aqua(1,10-phenanthroline)lead(ii)]-bis(l 3-2-hydroxy-5-sulfonatobenzoato)] acetic acid

More information

metal-organic compounds

metal-organic compounds metal-organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Di-l 2 -acetato-1:2j 2 O:O 0 ;2:3j 2 O:O 0 -bis- (N,N 0 -dimethylformamide)-1jo,3jobis{l 2-2,2 0 -[propane-1,3-diylbis(iminomethylene)]diphenolato-1j

More information

Supporting Information

Supporting Information Supporting Information A Regioselective Ring-Expansion of Isatins with In-situ Generated α-aryldiazomethanes; Direct Access to Viridicatin Alkaloids Yellaiah Tangella,, Kesari Lakshmi Manasa,, Namballa

More information

Experimental. Crystal data. C 26 H 34 F 2 N 6 S M r = Monoclinic, P2 1 =n a = (11) Å b = (6) Å c = (14) Å = 92.

Experimental. Crystal data. C 26 H 34 F 2 N 6 S M r = Monoclinic, P2 1 =n a = (11) Å b = (6) Å c = (14) Å = 92. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 3-(Adamantan-1-yl)-4-[(E)-(2,6-difluoro- benzylidene)amino]-1-[(4-ethylpiperazin- 1-yl)methyl]-4,5-dihydro-1H-1,2,4-triazole-5-thione

More information

Experimental. Crystal data. C 24 H 25 NOSi M r = Monoclinic, P2 1 =c a = (3) Å b = (19) Å c = (6) Å = 124.

Experimental. Crystal data. C 24 H 25 NOSi M r = Monoclinic, P2 1 =c a = (3) Å b = (19) Å c = (6) Å = 124. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 N-[(9H-Fluoren-9-ylidene)(2-methoxyphenyl)methyl]-1,1,1-trimethylsilanamine Zhong-Yuan Li, Peng Wang and Xia Chen*

More information

Limonin isolated from the seeds of Citrus limetta (Indian sweet lemon)

Limonin isolated from the seeds of Citrus limetta (Indian sweet lemon) Limonin isolated from the seeds of Citrus limetta (Indian sweet lemon) ISSN 2414-3146 A. K. Bauri, a Sabine Foro b and Quynh Nguyen Do Nhu c * Received 18 January 2016 Accepted 27 January 2016 Edited by

More information

A 3D Porous Metal-Organic Framework Exhibiting Selective. Adsorption of Water over Organic Solvents

A 3D Porous Metal-Organic Framework Exhibiting Selective. Adsorption of Water over Organic Solvents Supporting Information for A 3D Porous Metal-Organic Framework Exhibiting Selective Adsorption of Water over Organic Solvents Jin-Zhong Gu, Long Jiang, Wen-Guan Lu, Hong-Cai Zhou, and Tong-Bu Lu* Table

More information

Experimental. Crystal data. C 25 H 16 Cl 2 O 4 C 2 H 6 O M r = Tetragonal, I4 a = (5) Å c = (2) Å V = 4676.

Experimental. Crystal data. C 25 H 16 Cl 2 O 4 C 2 H 6 O M r = Tetragonal, I4 a = (5) Å c = (2) Å V = 4676. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 1,8-Bis(4-chlorobenzoyl)-7-methoxynaphthalen-2-ol ethanol monosolvate Ryosuke Mitsui, a Atsushi Nagasawa, a Keiichi

More information

Introduction to the Oligo HTCS Systems. Novatia, LLC

Introduction to the Oligo HTCS Systems. Novatia, LLC Introduction to the Oligo HTCS Systems Novatia, LLC What is the Oligo HTCS and what can it do? Automated ESI/MS system that can analyze up to 14 oligonucleotide samples/day (>3/day with twin autosampler)

More information

Experimental. Crystal data. C 24 H 19 N 3 O M r = Monoclinic, C2=c a = (2) Å b = (4) Å c = (12) Å = 113.

Experimental. Crystal data. C 24 H 19 N 3 O M r = Monoclinic, C2=c a = (2) Å b = (4) Å c = (12) Å = 113. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 3,5-Diphenyl-1-(quinolin-2-yl)-4,5- dihydro-1h-pyrazol-5-ol Muhd. Hidayat bin Najib, a Ai Ling Tan, a David J.

More information

Experimental. Crystal data

Experimental. Crystal data organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 1-(4-Methylphenylsulfonyl)-2-{[3-methyl- 4-(2,2,2-trifluoroethoxy)pyridin-2-yl]- methylsulfanyl}-1h-1,3-benzimidazole

More information

organic compounds N-Cinnamoyl-L-phenylalanine methyl ester Related literature References Experimental

organic compounds N-Cinnamoyl-L-phenylalanine methyl ester Related literature References Experimental organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 N-Cinnamoyl-L-phenylalanine methyl ester Laurent F. Bornaghi, Sally-Ann Poulsen, Peter C. Healy and Alan R. White*

More information

Analysis of Uncomplexed and Copper-complexed Methanobactin with UV/Visible Spectrophotometry, Mass Spectrometry and NMR Spectrometry

Analysis of Uncomplexed and Copper-complexed Methanobactin with UV/Visible Spectrophotometry, Mass Spectrometry and NMR Spectrometry Analysis of Uncomplexed and Copper-complexed Methanobactin with UV/Visible Spectrophotometry, Mass Spectrometry and NMR Spectrometry Lee Behling, Alan DiSpirito, Scott Hartsel, Larry Masterson, Gianluigi

More information

Multicomponent Self-Assembly of a Pentanuclear Ir-Zn Heterometal-Organic Polyhedron for Carbon Dioxide Fixation and Sulfite Sequestration

Multicomponent Self-Assembly of a Pentanuclear Ir-Zn Heterometal-Organic Polyhedron for Carbon Dioxide Fixation and Sulfite Sequestration Electronic Supplementary Material (ESI) for ChemComm. This journal is The Royal Society of Chemistry 2016 Multicomponent Self-Assembly of a Pentanuclear Ir-Zn Heterometal-Organic Polyhedron for Carbon

More information

Experimental. Crystal data. C 26 H 36 O 7 M r = Orthorhombic, P a = (2) Å b = (3) Å c = (3) Å.

Experimental. Crystal data. C 26 H 36 O 7 M r = Orthorhombic, P a = (2) Å b = (3) Å c = (3) Å. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 1,3,7-Trideacetylkhivorin Experimental Crystal data C 26 H 36 O 7 M r = 460.55 Orthorhombic, P2 1 2 1 2 1 a =

More information

yl}-3-oxo-1,2,5-thiadiazolidin-2-ide 1,1-dioxide: a potential inhibitor of the enzyme protein tyrosine phosphatase 1B (PTP1B)

yl}-3-oxo-1,2,5-thiadiazolidin-2-ide 1,1-dioxide: a potential inhibitor of the enzyme protein tyrosine phosphatase 1B (PTP1B) journals.iucr.org/e Crystal structure of 5-{4 -[(2-{2-[2-(2-ammonioethoxy)ethoxy]ethoxy}ethyl)carbamoyl]-4-methoxy-[1,1 -biphenyl]-3- yl}-3-oxo-1,2,5-thiadiazolidin-2-ide 1,1-dioxide: a potential inhibitor

More information

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras) C 19 H 30 N 5 O 10 P. C 4 H 4 O 4 Relative molecular mass. 635.5. Chemical names. bis(1-methylethyl) 5-{[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}-5-oxo-2,4,6,8-tetraoxa-5-λ 5 - phosphanonanedioate

More information

Supplementary Figures

Supplementary Figures Supplementary Figures Absorption 4 3 2 1 Intensity Energy U(R) relaxation ~~~ ~~~~~~ 2 3 4 1 S S 1 2 3 4 1 Fluoescence 4 3 2 1 Intensity H-aggregation ~~~~ J-aggregation Absorption Emission Vibrational

More information

Self-organization of dipyridylcalix[4]pyrrole into a supramolecular cage for dicarboxylates

Self-organization of dipyridylcalix[4]pyrrole into a supramolecular cage for dicarboxylates Electronic Supplementary Material (ESI) for RSC Advances. This journal is The Royal Society of Chemistry 2016 Electronic Supplementary Information Self-organization of dipyridylcalix[4]pyrrole into a supramolecular

More information

CHAPTER-6 IDENTIFICATION, AND CHARACTERISATION OF DEGRADATION IMPURITY IN VALSARTAN TABLETS

CHAPTER-6 IDENTIFICATION, AND CHARACTERISATION OF DEGRADATION IMPURITY IN VALSARTAN TABLETS 129 CHAPTER-6 IDENTIFICATION, AND CHARACTERISATION OF DEGRADATION IMPURITY IN VALSARTAN TABLETS 130 6.1. Introduction Valsartan is an orally active specific angiotensin II blocker effective in lowering

More information

Minutes Figure S1. HPLC separation of nucleosides from LC/ESI-MS analysis of a total enzymatic Trp

Minutes Figure S1. HPLC separation of nucleosides from LC/ESI-MS analysis of a total enzymatic Trp 100 A % Relative Abundance m m Ø acp 5 m Øm 5 m m 7 m s * 6 ia m * 0 5 10 15 0 5 0 5 40 Minutes Figure S1. HPL separation of nucleosides from L/ESI-MS analysis of a total enzymatic digest of mt trna. V

More information

A pillar[2]arene[3]hydroquinone which can self-assemble to a molecular zipper in the solid state

A pillar[2]arene[3]hydroquinone which can self-assemble to a molecular zipper in the solid state A pillar[2]arene[3]hydroquinone which can self-assemble to a molecular zipper in the solid state Mingguang Pan, Min Xue* Department of Chemistry, Zhejiang University, Hangzhou 310027, P. R. China Fax:

More information

metal-organic compounds

metal-organic compounds metal-organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Dichlorido(4,4 0 -di-tert-butyl-2,2 0 -bipyridine-j 2 N,N 0 )palladium(ii) dimethyl sulfoxide monosolvate

More information

Determination of taurine in energy drinks by high-performance liquid chromatography

Determination of taurine in energy drinks by high-performance liquid chromatography Determination of taurine in energy drinks by high-performance liquid chromatography Brad McConn Department of Chemistry, Concordia College, 901 8 th St S, Moorhead, MN 56562 Abstract The concentration

More information

Supporting Information

Supporting Information Supporting Information Cyclic Peptidyl Inhibitors against Human Peptidyl-Prolyl Isomerase Pin1 Tao Liu, Yu Liu, Hung-Ying Kao, *,, and Dehua Pei Table of Contents: Table S1. Structures of amino acid building

More information

organic papers Elaidic acid (trans-9-octadecenoic acid)

organic papers Elaidic acid (trans-9-octadecenoic acid) organic papers Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Elaidic acid (trans-9-octadecenoic acid) John Nicolson Low, a * Charlie Scrimgeour b and Peter Horton c a Department

More information

Experimental. Crystal data. C 22 H 32 O 4 M r = Triclinic, P1 a = (1) Å b = (1) Å c = (1) Å = (1) = 79.

Experimental. Crystal data. C 22 H 32 O 4 M r = Triclinic, P1 a = (1) Å b = (1) Å c = (1) Å = (1) = 79. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Methyl 3,5-bis(cyclohexylmethoxy)- benzoate Peter W. R. Corfield,* Michele L. Paccagnini and Amy M. Balija Department

More information

Z =4 Mo K radiation = 0.10 mm 1. Data collection. Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections

Z =4 Mo K radiation = 0.10 mm 1. Data collection. Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 N,N 0,N 00 -Triphenylguanidinium 5-nitro- 2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1- ide P. S. Pereira Silva, S.

More information

Data collection. Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 283 parameters

Data collection. Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 283 parameters organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Dimethylammonium 3-carboxybenzoate Tausif Siddiqui, Vandavasi Koteswara Rao, Matthias Zeller and Sherri R. Lovelace-Cameron*

More information

research communications Crystal structure of nitrido[5,10,15,20-tetrakis(4- methylphenyl)porphyrinato]manganese(v)

research communications Crystal structure of nitrido[5,10,15,20-tetrakis(4- methylphenyl)porphyrinato]manganese(v) research communications Crystal structure of nitrido[5,10,15,20-tetrakis(4- methylphenyl)porphyrinato]manganese(v) ISSN 1600-5368 Mason R. Shields, a Ilia A. Guzei b * and James G. Goll a Received 29 July

More information

Metabion GmbH, Germany

Metabion GmbH, Germany Metabion GmbH, Germany CUSTOM OLIGO NUCLEOTIDE SYNTHESIS DNA Single Tube Format (price per base) Scale Standard Yield OPC Purified Yield HPLC Purified Yield (µmol) Rs (OD 260 ) Rs (OD 260 ) Rs (OD 260

More information

Direct ortho-c H Functionalization of Aromatic Alcohols Masked by Acetone Oxime Ether via exo-palladacycle

Direct ortho-c H Functionalization of Aromatic Alcohols Masked by Acetone Oxime Ether via exo-palladacycle Direct ortho-c H Functionalization of Aromatic Alcohols Masked by Acetone Oxime Ether via exo-palladacycle Kun Guo, Xiaolan Chen, Mingyu Guan, and Yingsheng Zhao* Key Laboratory of Organic Synthesis of

More information

dimethylformamide monosolvate

dimethylformamide monosolvate research communications ISSN 2056-9890 Crystal structure of N-[6-amino-5-(benzo[d]thiazol- 2-yl)-3-cyano-4-methylsulfanyl-2-oxo-1,2-dihydropyridin-1-yl]-4-methylbenzenesulfonamide dimethylformamide monosolvate

More information

Monoclinic, P2 1 =n a = (9) Å b = (8) Å c = (11) Å = (1) V = (2) Å 3. Data collection.

Monoclinic, P2 1 =n a = (9) Å b = (8) Å c = (11) Å = (1) V = (2) Å 3. Data collection. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 2-[2-(4-Bromophenyl)hydrazinylidene]- 1,3-diphenylpropane-1,3-dione Carlos Bustos, a Luis Alvarez-Thon, b * Juan-Guillermo

More information

Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 405 parameters 12 restraints

Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 405 parameters 12 restraints organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 4-Nitrophenyl a-l-rhamnopyranoside hemihydrate 1 Jianbo Zhang, a * Jie Fu, a Xuan Chen, a Yijun Gu b and Jie Tang

More information

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System Application Note Food Testing and Agriculture Mass-Based Purification of Natural Product Impurities Using an Agilent 126 Infinity II Preparative LC/MSD System Authors Florian Rieck and Jörg Hippler Agilent

More information

Supplementary Materials for

Supplementary Materials for advances.sciencemag.org/cgi/content/full/2/4/e1500980/dc1 Supplementary Materials for The crystal structure of human dopamine -hydroxylase at 2.9 Å resolution Trine V. Vendelboe, Pernille Harris, Yuguang

More information

Supporting Information

Supporting Information Supporting Information A new series of cytotoxic pyrazoline derivatives as potential anticancer agents induces cell cycle arrest and apoptosis Hong Wang 1,, Jinhong Zheng 1,, Weijie Xu 1, Cheng Chen 1,

More information

Guajavadimer A, a dimeric caryophyllene-derived meroterpenoid with a new carbon skeleton from the leaves of Psidium guajava.

Guajavadimer A, a dimeric caryophyllene-derived meroterpenoid with a new carbon skeleton from the leaves of Psidium guajava. Guajavadimer A, a dimeric caryophyllene-derived meroterpenoid with a new carbon skeleton from the leaves of Psidium guajava. Chuang-Jun Li, Jie Ma, Hua Sun, Dan Zhang, and Dong-Ming Zhang* State Key Laboratory

More information

metal-organic compounds

metal-organic compounds metal-organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Diaqua[(1R,2S,4R,8R,9S,11R)-2,9-dimethyl-1,4,8,11-tetraazacyclotetradecane]nickel(II) dichloride dihydrate

More information

Data collection. Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 225 parameters

Data collection. Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 225 parameters organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 Dicyclohexylammonium 2-methoxybenzoate Nenad Judaš a * and Tomislav Portada b Data collection Oxford Diffraction

More information

Supporting Information. 58 Pages. 6 Figures 4 Tables

Supporting Information. 58 Pages. 6 Figures 4 Tables Light-Source-Dependent Effects of Main Water Constituents on Photodegradation of Phenicol Antibiotics: Mechanism and Kinetics Linke Ge, Jingwen Chen, * Xianliang Qiao, Jing Lin, Xiyun Cai Key Laboratory

More information

SUPPLEMENTAL DATA. Cytochrome P450-type hydroxylation and epoxidation in a tyrosine-liganded hemoprotein, catalase-related allene oxide synthase

SUPPLEMENTAL DATA. Cytochrome P450-type hydroxylation and epoxidation in a tyrosine-liganded hemoprotein, catalase-related allene oxide synthase SUPPLEMENTAL DATA Cytochrome P450-type hydroxylation and epoxidation in a tyrosine-liganded hemoprotein, catalase-related allene oxide synthase William E. Boeglin & Alan R. Brash Fig. S1 SP-HPLC separation

More information

metal-organic compounds

metal-organic compounds metal-organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 b = 19.1695 (15) Å c = 16.6178 (14) Å = 90.786 (6) V = 2077.4 (3) Å 3 Z =4 Mo K radiation = 1.34 mm 1 T

More information

Experimental. Crystal data. C 26 H 30 N 2 M r = Triclinic, P1 a = (3) Å b = (4) Å c = (5) Å = (2) = 77.

Experimental. Crystal data. C 26 H 30 N 2 M r = Triclinic, P1 a = (3) Å b = (4) Å c = (5) Å = (2) = 77. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 (E)-N-[2-(Benzyliminomethyl)phenyl]- 2,6-diisopropylaniline Yi-Chang Liu, a Chia-Her Lin, a Hsiao-Li Chen b and

More information

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page: IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page: ISSN: 2320-2831 Research article Open Access Method development and validation of tenofovir disoproxil fumerate and emtricitabine in combined tablet

More information

Naoya Takahashi, Keiya Hirota and Yoshitaka Saga* Supplementary material

Naoya Takahashi, Keiya Hirota and Yoshitaka Saga* Supplementary material Supplementary material Facile transformation of the five-membered exocyclic E-ring in 13 2 -demethoxycarbonyl chlorophyll derivatives by molecular oxygen with titanium oxide in the dark Naoya Takahashi,

More information

Challenges in Artemisinin

Challenges in Artemisinin Challenges in Artemisinin Analysis Bhupinder P S Khambay and Aditi Gulati Kamtech Technologies Ltd Artemisinin Conference 2010 12 th -14 th October 2010 in Antananarivo, Madagascar Outline of Presentation

More information

SUPPLEMENTARY DATA. Materials and Methods

SUPPLEMENTARY DATA. Materials and Methods SUPPLEMENTARY DATA Materials and Methods HPLC-UV of phospholipid classes and HETE isomer determination. Fractionation of platelet lipid classes was undertaken on a Spherisorb S5W 150 x 4.6 mm column (Waters

More information

Experimental. Crystal data. C 30 H 48 ClN 3 O M r = Orthorhombic, P a = (2) Å b = (3) Å c = 26.

Experimental. Crystal data. C 30 H 48 ClN 3 O M r = Orthorhombic, P a = (2) Å b = (3) Å c = 26. organic compounds Acta Crystallographica Section E Structure Reports Online ISSN 1600-5368 3b-Chloro-6-[2-(2-cyanoacetyl)hydrazin- 1-ylidene]-5a-cholestane Samina Khan Yusufzai, a Hasnah Osman, a Aisyah

More information

Ultra High Performance Liquid Chromatograph. Nexera X2 C196-E079

Ultra High Performance Liquid Chromatograph. Nexera X2 C196-E079 Ultra High Performance Liquid Chromatograph Nexera X2 C196-E79 Maximizing the Potential of UHPLC/HPLC Analyses Intelligence Intelligent data solutions, including a new i -PDeA peak calculation method for

More information

Synthesis of Sequence-Controlled Acrylate Oligomers. via Consecutive RAFT Monomers Additions

Synthesis of Sequence-Controlled Acrylate Oligomers. via Consecutive RAFT Monomers Additions Supporting Information Synthesis of Sequence-Controlled Acrylate ligomers via Consecutive RAFT Monomers Additions Joke Vandenbergh a, Gunther Reekmans, b Peter Adriaensens b and Thomas Junkers a * a Polymer

More information

Thermal shift binding experiments were carried out using Thermofluor 384 ELS system. Protein

Thermal shift binding experiments were carried out using Thermofluor 384 ELS system. Protein Supplementary Methods Thermal shift assays Thermal shift binding experiments were carried out using Thermofluor 384 ELS system. Protein unfolding was examined by monitoring the fluorescence of ANS (1-anilinonaphthalene-8-

More information

Glycerolipid Analysis. LC/MS/MS Analytical Services

Glycerolipid Analysis. LC/MS/MS Analytical Services Glycerolipid Analysis LC/MS/MS Analytical Services Molecular Characterization and Quantitation of Glycerophospholipids in Commercial Lecithins by High Performance Liquid Chromatography with Mass Spectrometric

More information

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016 Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica This

More information